Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and the food effect of single and multiple doses of HRS-3095 in healthy subj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• HRS-3095 (HRS-3095)

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Chronic Spontaneous Urticaria | Phase 1 | Status: RECRUITING